Role of Protein Ubiquitination in Sepsis
Role of Protein Ubiquitination in Sepsis
批准号:
9175444
负责人:
JIAN ZHANG
金额:
$34.01万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-06-24 至 2021-05-31
关键词:
AttenuatedBindingBiologicalCASP1 geneCaringCaspaseCell WallCessation of lifeComplexDataDeubiquitinating EnzymeDevelopmentDoseEndotoxinsEnzymesFeedbackGenetic PolymorphismGram-Negative BacteriaHealthcare SystemsHumanImmune responseImmunityIn VitroInfectionInflammatoryInflammatory ResponseInjection of therapeutic agentInjuryInterleukin-1Interleukin-1 betaLeadLeucine-Rich RepeatLigationLinkLipopolysaccharidesMediatingMedicalMedicineMolecularMorbidity - disease rateMusMutationPatientsPhosphorylationPolyubiquitinationProductionProteinsPuncture procedureRoleSepsisSepsis SyndromeSeptic ShockSignal PathwaySignal TransductionSiteStressStudy modelsTestingTherapeuticTimeTyrosine PhosphorylationUbiquitinationWild Type Mouseattenuationcaspase 12combatcostcytokinecytosolic receptorin vivoinsightmacrophagemicrobialmortalitynovelpathogenpreventprotein complexreceptorresearch studyresponsesensorsepticsrc-Family Kinasesubiquitin ligaseubiquitin-protein ligase
中文摘要
项目摘要
败血症及其并发症是当代医学面临的一大挑战。大约25万例
败血症每年在美国导致死亡,给医疗保健系统带来了巨大的成本。取决于
根据医疗标准,全球败血症患者的死亡率从30%到70%不等,
总死亡率约为50%。NLRP3是大分子信号复合体的关键组成部分,称为
炎症体促进依赖caspase1的IL-1β促炎细胞因子的产生
在脓毒症的发展过程中。尽管导致NLRP3炎症体激活的因素已经被
经过广泛研究,负性调节NLRP3炎症体激活的机制,以及
因此,对脓毒症的控制,尚不清楚。我们发现NLRP3被泛素化抑制,Cbl-b是一种E3
泛素连接酶。这一发现的意义在于观察到,内毒素
与注射或盲肠结扎穿孔(CLP)相比,注射(LP)或盲肠结扎穿孔(CLP)可显著降低Cblb-/-小鼠的死亡率
野生型(WT)对照,这种由内毒素诱导的Cblb-/-小鼠死亡率增加可被IL-1阻断
受体拮抗剂或通过引入NLRP3缺乏症。因此,我们的中心假设是,在脓毒症期间,
CBL-b被自动激活/激活,泛素化NLRP3,进而抑制NLRP3并减弱
NLRP3介导的先天反应。我们建议确定1)Cbl-b如何调节NLRP3炎症体
激活;2)Cb1-b是否以及如何利用CLP诱导体内控制非典型性NLRP3炎症体
以脓毒症和内毒素感染性休克为研究模型。了解Cbl-b在调节细胞周期中的作用
NLRP3炎症小体介导的信号通路将为临床治疗提供新的思路和策略
与败血症作斗争。
英文摘要
Project Summary
Sepsis with its complications is a major challenge in contemporary medicine. Approximately 250,000 cases of
sepsis lead to fatalities in the USA annually at huge costs for the healthcare system. Depending on the
standards of medical care, the worldwide mortality rates in septic humans range from 30% to 70% with an
aggregate mortality rate of ~50%. NLRP3 is a key component of the macromolecular signaling complex called
the inflammasome that promotes caspase 1-dependent production of IL-1β pro-inflammatory cytokine involved
in the development of sepsis. Although the factors leading to NLRP3 inflammasome activation have been
extensively studied, the mechanisms for negatively regulating the activation of the NLRP3 inflammasome, and
thus, controlling sepsis, are not known. We found that NLRP3 is inhibited by ubiquitination by Cbl-b, an E3
ubiquitin ligase. The significance of this finding is demonstrated by the observation that that lipopolysaccharide
(LPS) injection or cecal ligation and puncture (CLP) induces a significant mortality in Cblb-/- mice compared to
wild-type (WT) controls, and this increased mortality in Cblb-/- mice induced by LPS is blocked by an IL-1
receptor antagonist or by introducing NLRP3 deficiency. Therefore, our central hypothesis is that during sepsis,
Cbl-b is autoubiquitinated/activated and ubiquitinates NLRP3, which in turn inhibits NLRP3 and attenuates
NLRP3-mediated innate responses. We propose to determine 1) how Cbl-b regulates NLRP3 inflammasome
activation; 2) whether and how Cbl-b controls non-canonical NLRP3 inflammasome in vivo using CLP-induced
sepsis and LPS-induced septic shock as the study models. Understanding the role of Cbl-b in regulating the
NLRP3 inflammasome-mediated signaling pathway will provide novel insights and therapeutic strategies to
combat sepsis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of Protein Ubiquitination in Sepsis
-
批准号:9551775
-
项目类别:
-
资助金额:$28.74万
-
财政年份:2017
-
负责人:JIAN ZHANG
-
依托单位:
NEDD4 IN T HELPER CELL DEVELOPMENT AND AUTOIMMUNITY
-
批准号:9547050
-
项目类别:
-
资助金额:$51.41万
-
财政年份:2017
-
负责人:JIAN ZHANG
-
依托单位:
Regulation of Innate Immune System Sensing of C. albicans Infection
-
批准号:9262609
-
项目类别:
-
资助金额:$1.32万
-
财政年份:2016
-
负责人:JIAN ZHANG
-
依托单位:
Role of Protein Ubiquitination in Sepsis
-
批准号:9303271
-
项目类别:
-
资助金额:$5.27万
-
财政年份:2016
-
负责人:JIAN ZHANG
-
依托单位:
SBIR TOPIC321:CHEMICALLY DEFINED GLYCAN LIBRARIES FOR REFERENCE STANDARDS AND GLY
-
批准号:8758458
-
项目类别:
-
资助金额:$29.9万
-
财政年份:2013
-
负责人:JIAN ZHANG
-
依托单位:
Cbl-b in T Cell Activation and Autoimmunity
-
批准号:8616842
-
项目类别:
-
资助金额:$16.34万
-
财政年份:2013
-
负责人:JIAN ZHANG
-
依托单位:
Cbl-b in T Cell Activation and Autoimmunity
-
批准号:8493776
-
项目类别:
-
资助金额:$35.71万
-
财政年份:2013
-
负责人:JIAN ZHANG
-
依托单位:
STEADY-STATE FREE PRECESSION DIFFUSION IMAGING USING 3D ROTATING SPIRALS
-
批准号:8362916
-
项目类别:
-
资助金额:$1.95万
-
财政年份:2011
-
负责人:JIAN ZHANG
-
依托单位:
MAJOR INSTUMENTATION CORE
-
批准号:8357084
-
项目类别:
-
资助金额:$54.58万
-
财政年份:2011
-
负责人:JIAN ZHANG
-
依托单位:
MAJOR INSTUMENTATION CORE
-
批准号:8166222
-
项目类别:
-
资助金额:$66.33万
-
财政年份:2010
-
负责人:JIAN ZHANG
-
依托单位:
Measurement of CCR5 and CCL3L1 on Single Cell by Fluorescent Metal Nanoparticle
-
批准号:7740301
-
项目类别:
-
资助金额:$21.0万
-
财政年份:2009
-
负责人:JIAN ZHANG
-
依托单位:
Measurement of CCR5 and CCL3L1 on Single Cell by Fluorescent Metal Nanoparticle
-
批准号:7904766
-
项目类别:
-
资助金额:$18.56万
-
财政年份:2009
-
负责人:JIAN ZHANG
-
依托单位:
ALTERED T-CELL ACTIVATION IN AUTOIMMUNE ARTHRITIS
-
批准号:7393777
-
项目类别:
-
资助金额:$18.69万
-
财政年份:2007
-
负责人:JIAN ZHANG
-
依托单位:
A Novel Protection Device for Shock Wave Lithotripter
-
批准号:6993066
-
项目类别:
-
资助金额:$9.11万
-
财政年份:2005
-
负责人:JIAN ZHANG
-
依托单位:
Cbl-b in T Cell Activation and Autoimmunity
-
批准号:6821748
-
项目类别:
-
资助金额:$31.22万
-
财政年份:2004
-
负责人:JIAN ZHANG
-
依托单位:
Cbl-b in T Cell Activation and Autoimmunity
-
批准号:7103405
-
项目类别:
-
资助金额:$30.49万
-
财政年份:2004
-
负责人:JIAN ZHANG
-
依托单位:
Cbl-b in T Cell Activation and Autoimmunity
-
批准号:7436128
-
项目类别:
-
资助金额:$29.01万
-
财政年份:2004
-
负责人:JIAN ZHANG
-
依托单位:
Cbl-b in T Cell Activation and Autoimmunity
-
批准号:7241548
-
项目类别:
-
资助金额:$29.61万
-
财政年份:2004
-
负责人:JIAN ZHANG
-
依托单位:
ALTERED T-CELL ACTIVATION IN AUTOIMMUNE ARTHRITIS
-
批准号:6895963
-
项目类别:
-
资助金额:$11.36万
-
财政年份:2004
-
负责人:JIAN ZHANG
-
依托单位:
Cbl-b in T Cell Activation and Autoimmunity
-
批准号:6952385
-
项目类别:
-
资助金额:$31.22万
-
财政年份:2004
-
负责人:JIAN ZHANG
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: